Bluesky Facebook Reddit Email

Prognostic power of the micropapillary pattern in pancreatic ductal adenocarcinoma: A game changer

01.20.25 | Xia & He Publishing Inc.

Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C)

Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C) keeps Macs, tablets, and meters powered during extended observing runs and remote surveys.

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy characterized by distinct histological subtypes and a poor prognosis. Among these, the micropapillary pattern, typically observed focally, has been associated with worse outcomes in various cancers. This study aimed to evaluate the prognostic significance of the micropapillary pattern in PDAC, focusing on its percentage within the tumor and its impact on overall survival.

A retrospective analysis was conducted on 71 patients with surgically resected PDAC. Micropapillary patterns were categorized based on their percentage within the tumor (≥20%) and compared to non-micropapillary cases. Demographic, clinical, and histological data, including tumor nodule metastasis stage, tumor grade, peripancreatic fat tissue invasion, and resection margin status, were analyzed. Survival data were assessed using Kaplan-Meier and Cox proportional hazards models. A p -value < 0.05 was considered statistically significant.

The cohort included 28 female and 43 male patients, with a mean age of 63.25 years. Of the 71 cases, 23.9% (n = 17) exhibited a micropapillary pattern. The median overall survival for the micropapillary group was eight months, compared to 18 months for the non-micropapillary group ( p = 0.017). Multivariate analysis revealed that the micropapillary group had an increased risk of mortality (hazard ratio = 1.892, p = 0.042), independent of tumor nodule metastasis stage.

Our findings indicate that the micropapillary pattern, even when present in as little as 20% of the tumor, serves as an independent prognostic factor for decreased survival in PDAC. Incorporating the percentage of the micropapillary pattern into pathology reports could provide valuable insights into the tumor’s biological behavior, potentially enhancing patient management strategies.

Full text

https://www.xiahepublishing.com/2771-165X/JCTP-2024-00045

The study was recently published in the Journal of Clinical and Translational Pathology .

Journal of Clinical and Translational Pathology (JCTP) is the official scientific journal of the Chinese American Pathologists Association (CAPA). It publishes high quality peer-reviewed original research, reviews, perspectives, commentaries, and letters that are pertinent to clinical and translational pathology, including but not limited to anatomic pathology and clinical pathology. Basic scientific research on pathogenesis of diseases as well as application of pathology-related diagnostic techniques or methodologies also fit the scope of the JCTP.

Follow us on X: @xiahepublishing

Follow us on LinkedIn: Xia & He Publishing Inc.

Journal of Clinical and Translational Pathology

10.14218/JCTP.2024.00045

Prognostic Power of the Micropapillary Pattern in Pancreatic Ductal Adenocarcinoma: A Game Changer

30-Dec-2024

Keywords

Article Information

Contact Information

Shelly Zhang
Xia & He Publishing Inc.
service@xiahepublishing.com

Source

How to Cite This Article

APA:
Xia & He Publishing Inc.. (2025, January 20). Prognostic power of the micropapillary pattern in pancreatic ductal adenocarcinoma: A game changer. Brightsurf News. https://www.brightsurf.com/news/12D7M7X1/prognostic-power-of-the-micropapillary-pattern-in-pancreatic-ductal-adenocarcinoma-a-game-changer.html
MLA:
"Prognostic power of the micropapillary pattern in pancreatic ductal adenocarcinoma: A game changer." Brightsurf News, Jan. 20 2025, https://www.brightsurf.com/news/12D7M7X1/prognostic-power-of-the-micropapillary-pattern-in-pancreatic-ductal-adenocarcinoma-a-game-changer.html.